Davies T F, Concepcion E S, Ben-Nun A, Graves P N, Tarjan G
Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029.
J Clin Endocrinol Metab. 1993 Mar;76(3):660-6. doi: 10.1210/jcem.76.3.8445022.
We have examined the hTcR V gene family use of T-cells present in the aspiration thyroid biopsy specimens of patients with hyperthyroid Graves' disease (n = 8) and Hashimoto's autoimmune thyroiditis (n = 5). Nine of the 13 specimens had cytologically identified thyroid follicular cells, and 12 of the 13 contained human thyroglobulin-specific mRNA, confirming successful sampling. Of 18 hTcR V alpha and 19 hTCR V beta gene families tested for in the individual aspirates, a mean +/- SEM of 6.8 +/- 0.9 V alpha and 9.6 +/- 1.4 V beta gene families were present in the Graves' aspirates, while 12.2 +/- 1.7 and 16.8 +/- 0.4 V alpha and V beta gene families were present in the aspirates of patients with Hashimoto's thyroiditis. These samples, which offer a window onto the natural history of autoimmune thyroid disease, demonstrate significant hTcR V alpha and beta gene restriction in hyperthyroid Graves' disease, but much less restriction of both V alpha and V beta gene families in Hashimoto's disease. Such data extend our earlier information based only on examination of highly selected surgical specimens of patients with autoimmune thyroid disease to the much more typical patient. We conclude that hTcR V gene restriction of varying degrees is present in the majority of patients with autoimmune thyroid disease, but appears to be more easily detected in Graves', rather that Hashimoto's, disease.
我们检测了甲状腺功能亢进的格雷夫斯病患者(n = 8)和桥本氏自身免疫性甲状腺炎患者(n = 5)甲状腺穿刺活检标本中T细胞的hTcR V基因家族使用情况。13份标本中有9份在细胞学上鉴定出甲状腺滤泡细胞,13份中有12份含有人类甲状腺球蛋白特异性mRNA,证实采样成功。在对各个穿刺样本检测的18个hTcR Vα和19个hTCR Vβ基因家族中,格雷夫斯病穿刺样本中平均±标准误为6.8±0.9个Vα基因家族和9.6±1.4个Vβ基因家族,而桥本氏甲状腺炎患者的穿刺样本中分别有12.2±1.7个和16.8±0.4个Vα和Vβ基因家族。这些样本为自身免疫性甲状腺疾病的自然史提供了一个窗口,显示出甲状腺功能亢进的格雷夫斯病中hTcR Vα和β基因有显著限制,但在桥本氏病中Vα和Vβ基因家族的限制要少得多。这些数据将我们之前仅基于对自身免疫性甲状腺疾病患者高度选择的手术标本检查所获得的信息扩展到了更具代表性的患者群体。我们得出结论,大多数自身免疫性甲状腺疾病患者存在不同程度的hTcR V基因限制,但在格雷夫斯病中似乎比在桥本氏病中更容易检测到。